US Trade Rep May Take Enforcement Actions Against India Over Device Price Controls
Executive Summary
US Trade Representative Robert Lighthizer told Senate Finance Committee Chairman Orrin Hatch, R-Utah, that if India's ongoing practices to impose price controls on US device imports continue, he would consider "enforcement actions," if India's actions violated any World Trade Organization trading rules.
You may also be interested in...
India-US Tensions Grow In Device Pricing Cap Controversy
India's price capping for medical devices is threatening to snowball into a trade tit-for-tat with the US. The US Trade Representative is intervening on the matter at the behest of industry. While a middle path is probably still possible, pro-health groups in India have decried the “reprehensible” US move, and others are suggesting a tax on US luxury goods should the issue escalate.
Lawmakers Prod Trump To Talk Trade Barriers, Stent Price Caps With India's Modi
US President Trump met with India Prime Minister Modi June 26 in Washington, DC. Trade barriers were one topic on the agenda, and lawmakers in Congress has suggested recent price caps placed on coronary stents in India as one specific issue that should get attention from the leaders.
India’s Simmering Device-Pricing Controversy – Many Hues
An uneasy calm prevails in the medical devices sector in India following regulatory action to cap stent prices and, more recently, a price data-gathering initiative for certain other products. Is this just the lull before another, more turbulent storm that lies ahead for industry?